A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): A single center study

Bone Marrow Transplantation

Volumn 25, Issue , 2000, Pages S27-S31

  Fauser, A A ^a   Basara, N ^a   Blau, I W ^a   Kiehl, M G ^a  

^a Bone Marrow Transplantation Clinic   (Germany)

Author keywords

Acute GVHD; Leukemia; Peripheral blood stem cell transplant; Unrelated donor

Indexed keywords

ETOPOSIDE; MELPHALAN; THIOTEPA;

ADULT; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECURRENCE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033935030     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702349     Document Type: Article

References (19)

1. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood-derived, T cell-depleted hematopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643-646.
2. Schmitz N, Bacigalupo A, Labopin M et al. Transplantation of allogeneic peripheral blood progenitor cells-the EBMT experience. Bone Marrow Transplant 1996; 17: 40-46.
3. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donorderived primitive hematopoietic progenitor cells (CD341 Thy- dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2848.
4. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996; 17: 703-708.
5. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood progenitor cell transplantation in patients with advanced hematologic malignancies; a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
6. Ottinger HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779.
7. Sierra J, Storer B, Hansen JA et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemia burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 4226-4235.
8. Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of shortterm engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 1996; 18: 35-40.
9. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705-4709.
10. Scott MA, Gandhi MK, Jestice HK et al. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study. Bone Marrow Transplant 1998; 22: 273-277.
11. Anderlini P, Przepiorka D, Körbling M, Champlin R. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant 1998; 21: (Suppl. 3): 35-39.
12. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1889.
13. Ringden O, Lönnqvist B, Hägglind H et al. Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease. Bone Marrow Transplant 1995; 16: 856-857.
14. Stockschläder M, Löliger C, Krüger W et al. Transplantation of allogeneic rhG-CSF mobilized peripheral CD341 cells from an HLA-identical unrelated donor. Bone Marrow Transplant 1995; 16: 719-721.
15. Hägglund H, Ringden O, Remberger M et al. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival using peripheral blood stem cells from related and unrelated donors, compared to bone marrow. Bone Marrow Transplant 1998; 22: 131-136.
16. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation, parts I, II. New Engl J Med 1975; 293: 832-840, 895-901.
17. Shulman HM, Sullivan KM, Weiden PI et al. Chronic graftversus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-210.
18. Armitage P, Berry G. Statistical Methods in Medical Research. Blackwell Science: Oxford, 1987.
19. Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation. Blood 1999; 94: 455-464.